RD, C., MA, W., WC, B., JA, R., CT, P., J, M., . . . PJ, M. (2021). Implications for Systemic Approaches to COVID-19: Effect Sizes of Remdesivir, Tocilizumab, Melatonin, Vitamin D3, and Meditation. Journal of inflammation research, 14, 4859. https://doi.org/10.2147/JIR.S323356
Chicago Style (17th ed.) CitationRD, Castle, Williams MA, Bushell WC, Rindfleisch JA, Peterson CT, Marzolf J, Brouwer K, and Mills PJ. "Implications for Systemic Approaches to COVID-19: Effect Sizes of Remdesivir, Tocilizumab, Melatonin, Vitamin D3, and Meditation." Journal of Inflammation Research 14 (2021): 4859. https://doi.org/10.2147/JIR.S323356.
MLA (9th ed.) CitationRD, Castle, et al. "Implications for Systemic Approaches to COVID-19: Effect Sizes of Remdesivir, Tocilizumab, Melatonin, Vitamin D3, and Meditation." Journal of Inflammation Research, vol. 14, 2021, p. 4859, https://doi.org/10.2147/JIR.S323356.